Form 4 for KURA Kura Oncology, Inc.
Accepted 2025-01-28 00:00:00 ET · period of report 2025-01-28 · accession 0000950170-25-010116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-28 | 2025-01-28 | KURA | Powl Brian T. | Chief Commercial Off | S - Sale | $7.87 | -1,583 | 59.7K | -3% | -$12.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | S | D | 1,583 | $7.87 | 59,667 | D | — | — | (F1) Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. |